Ocuphire Pharma Inc. (OCUP)
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 8:00 PM
13F Institute Ownership
Total Institutes of 38 in Ocuphire Pharma reduced their positions with a decrease of 12 investors compared to the previous quarter. A reduction of 709.17K shares, as total invested capital declined by $2.7M with ownership percentage dropping from 15.63% to 10.87%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.000
1.00
Call Flow 2,000
50%
Put Flow 2,000
50%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Bios Capital Management, LP | 3.85% | 995.25K | +100.00% | 1.18M | 1.26% |
| Vanguard Group Inc | 3.84% | 992.2K | +0.00% | 1.18M | < 0.01% |
| Geode Capital Management, LLC | 1.22% | 313.98K | +15.32% | 373.72K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.